4//SEC Filing
AZAB MOHAMMAD 4
Accession 0001209191-22-060939
CIK 0001582313other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:29 PM ET
Size
7.1 KB
Accession
0001209191-22-060939
Insider Transaction Report
Form 4
AZAB MOHAMMAD
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-12-12−3,086→ 0 totalExercise: $2.68Exp: 2022-12-31→ Common Shares (3,086 underlying) - Exercise/Conversion
Common Shares
2022-12-12$2.68/sh+3,086$8,270→ 69,905 total
Footnotes (2)
- [F1]The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
- [F2]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001309653
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:29 PM ET
- Size
- 7.1 KB